Gantacurium Uses, Dosage, Side Effects and more
Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.
Gantacurium chloride administered to anesthetized and ventilated healthy volunteers, caused dose dependent transient decrease in arterial blood pressure, mild histamine release at higher doses and no consistent changes in pulmonary compliance.
| Attribute | Details |
|---|---|
| Trade Name | Gantacurium |
| Generic | Gantacurium |
| Type | |
| Formula | C53H69ClN2O14 |
| Weight | Average: 993.58 Monoisotopic: 992.4426355 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in anesthesia (unspecified).
Half Life
3.09±0.21 minutes
